Peter Attia MD#30 – Thomas Seyfried, Ph.D.: Controversial discussion—cancer as a mitochondrial metabolic disease?
At a glance
WHAT IT’S REALLY ABOUT
Seyfried argues cancer is metabolic; Attia presses him on evidence
- Seyfried traces his path from epilepsy and ketogenic diet research at Yale to cancer, after mouse experiments showed that calorie restriction, not a ganglioside-targeting drug, was shrinking brain tumors.
- He argues, following Otto Warburg, that all cancer cells have defective respiration and survive by fermentation, with ATP coming from glucose and glutamine through substrate-level phosphorylation, and that gene mutations are downstream effects.
- He proposes a 'press-pulse' therapy: press glucose down with diet, ketosis and possibly insulin, pulse glutamine with drugs like DON, and add hyperbaric oxygen, with surgery after the tumor shrinks.
- Attia challenges the claims on mitochondrial function, the biopsy-metastasis idea, and cancer mortality trends, and says he is bullish on metabolic therapy but wants it alongside immunotherapy and chemotherapy rather than as a replacement.
- The discussion centers on glioblastoma as the best test case, with Seyfried citing survivors on metabolic therapy, an Egyptian patient who lived 30 months, and unpublished data, while Attia urges publication and advocacy.
IDEAS WORTH REMEMBERING
5 ideasCalorie restriction drove the tumor shrinkage, not the drug
Seyfried's pair-weighted mouse control group had tumors the same size as the drug-treated group, which led him to conclude that lowering blood sugar was the active mechanism.
Seyfried holds that every cancer has defective respiration
He cites Pete Peterson's compilation of mitochondrial abnormalities and says cancers are always fermenters, and he distrusts cell-culture oxygen-consumption data.
Cancer ATP may come from mitochondrial substrate-level phosphorylation
Seyfried argues glutamine fuels substrate-level phosphorylation in the mitochondrial matrix, the missing piece of Warburg's theory, with glucose and glutamine as the two key fuels.
Ketones are meant to feed normal cells, not kill tumors
He says normal cells can burn ketones and become glucose-hungry, while tumor cells with damaged mitochondria cannot use them, creating a competitive disadvantage for the tumor.
Glutamine must be pulsed rather than chronically restricted
Because immune cells and the gut depend on glutamine, Seyfried proposes pulsing a drug like DON and then restoring glutamine, since diet alone cannot lower it.
WORDS WORTH SAVING
5 quotesWe evolved as a species to starve. I mean, our existence today is dependent on our ability to go long periods of time without eating.
— Thomas Seyfried
You prevent cancer by keeping your mitochondria healthy.
— Thomas Seyfried
The ketones are not to kill cancer cells. They're to provide the normal cells with a fuel as an alternative to glucose, that the tumor cells can't use.
— Thomas Seyfried
I don't think it's worth arguing about whether it's a genetic disease or metabolic disease. It's just a goddamn hard disease, and we need every therapy imaginable.
— Peter Attia
Our goal is to emerge from the therapy healthier than when you started.
— Thomas Seyfried
High quality AI-generated summary created from speaker-labeled transcript.
